Pandemic akin to war, lawyer tells Covid inquiry
Decisions were “finely balanced” and, with hindsight, might have been different, Fiona Scolding KC says.
Similar Posts
Captain Sir Tom Moore: What has happened to his legacy?
How much money did Captain Tom raise and why is his family under the spotlight?
Ozempic, other weight-loss drugs may strengthen New Year’s resolutions, experts say: Health goal ‘boost’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Biden administration’s Medicare drug price negotiations will face major tests in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare can negotiate down drug prices in 2024, setting the…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
Texas Woman Who Sued For Emergency Abortion Leaves State As Court Rules Against Her
The Texas Supreme Court permanently blocked a judge’s ruling allowing a Texas woman to have an emergency abortion, just hours after her lawyers said she was forced to travel out of state for the procedure. The court’s seven-page ruling comes days after it temporarily blocked the judge’s decision to let Kate Cox have an abortion….
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
